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Abstract 
Analyzing microarrays data is still a great challenge since 
existing methods produce huge amounts of useless results. We 
propose a new method called NoDisco for discovering novel-
ties in gene sequences obtained by applying data-mining tech-
niques to microarray data. Method: We identify popular 
genes, which are often cited in the literature, and innovative
genes, which are linked to the popular genes in the sequences 
but are not mentioned in the literature. We also identify popu-
lar and innovative sequences containing these genes. Biolo-
gists can thus select interesting sequences from the two sets 
and obtain the k-best documents. Results: We show the effi-
ciency of this method by applying it on real data used to deci-
pher the mechanisms underlying Alzheimer disease. Conclu-
sion: The first selection of sequences based on popularity and 
innovation help experts focus on relevant sequences while the 
top-k documents help them understand the sequences.
Keywords: 
Information Retrieval, DNA Microarrays, Alzheimer Disease
Introduction
Alzheimer's disease (AD) is one of the most common forms of 
dementia. In 2006, more than 26.6 million cases of Alzheimer
were declared. Due to the increasing number of cases (ex-
pected to be multiplied by 4 in 2050), discovering genes in-
volved in AD is becoming a priority for the biomedical com-
munity [1,2]. 
In recent years, DNA microarrays have been successfully used 
for numerous applications. They allow researchers to compare 
gene expression in different tissues, cells or conditions [3,4] 
and provide some information on the relative levels of expres-
sion of thousands of genes among samples (usually less than a 
hundred). Nevertheless, due to the amount of data available, 
processing them in a way that makes biomedical sense is still 
a major issue. Data mining techniques, such as [5,6,7], play a 
key role in discovering previously unknown knowledge and, 
in this context, it has been shown that they could be of great 
help to biologists in identify subsets of microarray data that 
could be useful for further analysis [8]. However, the amount 
of results obtained with these techniques is still huge and can-
not be easily analysed by the experts. 
In [8], we proposed a general process, called GeneMining
based on the mining of sequential patterns. The process starts 
with a table produced thanks to static experiments we con-
ducted to check the levels of expression of the genes. Each 
column corresponds to a microarray and each line to a gene. 
Each microarray measures the intensity of the gene that cor-
responds to the numerical value in a given cell. We describe in 
[9] an efficient algorithm to extract frequent patterns of corre-
lated genes ordered according to their level of expression. We 
extract only patterns that distinguish classes of individuals 
(e.g. AD vs. healthy). An example of such a pattern is 
<(MRVI1)(PGAP1,GSK3B)>,80% AD,10% H meaning that
“For 80% of AD individuals and 10% of healthy individuals, 
the level of expression of gene MRVI1 is lower than those of
PGAP1 and GSK3B, whose levels of expression are very 
close”. Although this method was useful, the way to select 
relevant patterns was not efficient. Depending on the values of 
parameters, we obtained from 1,000 to 100,000 patterns that 
were not easy to interpret.
In addition to the problem of the number of patterns, biolo-
gists have to face other difficulties. First, they have to link the 
spot on the microarray to a gene. As no standard exists for 
specifying names of genes, this is a difficult task. Second, they 
have to look for relevant publications concerning the genes
that interest them. Although some tools are now available to 
automatically extract information from microarray data 
[11,12], there is no user-friendly tool to search the literature 
for sequential patterns.
In this paper, we focus on sequential patterns and our aim is to 
discover novelties to help biologists analyze how genes inter-
act. Our contribution is three-fold: (i) We first help biologists 
select relevant sequences according to a specific topic and 
then to identify both popular genes (often available in the lit-
erature) and innovative genes (associated with popular genes 
in the patterns), (ii) for each sequence, we propose the top-k
relevant documents in the literature for their interpretation,
(iii) we propose a visualization tool to underline the relation-
ship between a pattern and its associated documents. 
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Figure 1: The NoDisco general process
General Process
Figure 1 illustrates the general process of NoDisco, an aid-tool 
for discovering innovative genes. Entries of the system are 
gene patterns obtained with an algorithm such as [9], some 
user information (e.g. study of Alzheimer disease) and a web-
service to a bibliographical database such as PubMed1. The 
workflow is organized in the following steps:
1. Document querying: Depending on the topic of inter-
est T (e.g., Alzheimer), the tool generates a set of quer-
ies (for each sequence S) in order to extract documents
associated with the topic denoted QsetS,T.
2. Popularity and Novelty Ranking: For genes and gene 
sequences, a popularity rank (taking into account the 
number of references to the gene in the literature) and a 
novelty rank (non popular genes linked to popular 
ones) are computed.
3. Selection of Relevant Sequences: Popular and innova-
tive sequences are proposed to the expert so he can se-
lect some of them depending on the information he is 
looking for.
4. Document Visualization: Top-k documents associated 
with selected sequences are organized in a sophisti-
cated way for visualisation.
We now describe the process in more detail.
1 PubMed is an electronic library of publications in the field of bio-
medical research that is available to the public:
http://www.ncbi.nlm.nih.gov/sites/entrez
Document querying 
For each sequence, a query is submitted to the PubMed Web 
Service to compute a popularity and novelty score for the se-
quence. Queries are defined as follows:
Query syntax: A query based on n terms with n-1 operators 
returns m documents: ?
???????????????????????????????????→???????????
The operators can be: ‘AND, ‘NOR’ and ‘OR’. The number of 
documents retrieved by a query is denoted ⏐????????⏐?
Gene designation: As detailed in [13], recognizing biological 
objects in natural language is a very difficult task for many 
reasons: The general lack of annotator agreement and naming 
conventions, excessive use of abbreviations, frequent use of 
synonyms and homonyms, biological objects often have 
names consisting of many individual words, such as ‘human 
T-cell leukaemia lymphotropic virus type 1 protein’, etc. For 
all these reasons, in the query, it is not possible to directly use
the names of a gene embedded in such a sequence. So, with 
the Entrez gene2 Web Service, we first look for all aliases of 
the genes and store them in a contextual Gene Dictionary 
called ????all_id (a dictionary by type of microarray). For ex-
ample, in ???????????one alias for the gene ???? is ???????????
???????
Query about sequences: To build a query associated with a
gene (e.g. ????), we group all aliases found in ????all_id with 
the operator ???? (e.g. ???????????????????????????). To 
build a query associated with a sequence (e.g.
???????????????), we compose the previous aliases of the 
two genes with the operator ‘???’ (e.g. ???????? ???
???????????????????????????????.?In the rest of this arti-
cle, we use the term ?????????for??????????????????????????
???where????????????are aliases of the gene?????????
Topics of interest: Not all the documents retrieved using the 
name of a given gene will be relevant for the biologist. Their 
number can be reduced by using the parameters available in 
the PubMed search engine such as:
• Standard parameters: Author, date, journal publication, 
language, accessibility (full or free text, abstract). 
• Parameters about the topic: Type of article (clinical 
trial, editorial, etc.), species (human, animal), sex 
(male, female), journal topic, etc.
For example, to build a query associated with the sequence 
??????????????? and the topic ??????????????, we com-
pose the preceding query and the topic with the operator 
?????:  ?????????????????????????????????????????
????????????????Operators can also be used to specify the
terms of the topics (e.g. ??????????????????????.
2 http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene
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Popularity and Novelty Ranking 
We use the number of documents retrieved for each gene to 
rank them according to their popularity and novelty.
Popularity of a gene: A gene ?? is popular if the number of 
documents dealing with this gene in the literature is greater 
than the defined threshold ????????????. For each gene ?? in 
????all_id, its popularity, ???????, according to a topic ?? ??????
???????????????????
For example, if ???????????????? and 
⏐?????????????????⏐????????????????  is popular.
Popularity of a sequence: A sequence ?i is popular if the 
proportion of popular genes in ?i is greater than the defined
threshold ???????????. For each sequence ?i, we compute its 
popularity, ???Si,T, according to a topic ? . Let ??i be the set of 
popular genes in a sequence ?i:
?
For example, ???????????????????????????? is a popu-
lar sequence for ????????????????because ???????????????
are popular (⏐????⏐?⏐?⏐??????
Innovative genes: A gene ?? is in an innovative relation with 
popular genes if the number of sequences associating ?? with 
popular genes is greater than the defined threshold 
????????????. For each gene ?? of ????all_id? we compute its 
novelty, New????, according to a topic T???????????i be the set 
of popular sequences containing ??:
For example, ???? is an innovative gene because it is pres-
ent in more than new_min_gene?popular sequences. 
Innovative sequences: A sequence ?i is innovative if the pro-
portion of innovative genes in ?i is greater than the defined
threshold ???????????. For each ?i, we compute its innova-
tive score, ???Si,T, according to a topic ?.. Let ??i be the set of 
innovative genes in a sequence ?i:
For example, if ???????????????? then? ?????????? ??????
???????????? is an innovative sequence as ????? and?
?????????are two innovative genes (⏐????⏐?⏐?⏐?????.
At the end of this step, we have reduced the initial set of se-
quences to two sets, popular and innovative sequences, which 
can be proposed as relevant sequences for the experts.
Top-k documents: To help the expert analyze a sequence ?i,
we look for the Top-? documents. To this end, we ask Pub-
Med to retrieve all documents ? associated with genes in ?i
and we rank them using the two following methods.
First, we compute the score ??? for a document ?i published in 
???? ????? ? and dealing with the ? genes. Let ???? (resp. 
????) be the year of publication of the oldest document 
(resp. the year of publication of the most recent document). 
Let ???? (resp. ????) be the minimum (resp. maximum)
number of genes cited in the documents of ?. 〈 is a coefficient.
We then rank the documents according to the equation 5. ??i ∈
[???]. 〈 ∈ [???]. The value 〈?????gives the same weight to 
both components of the formula.
?
Second, in the documents described by the two criteria (year 
of publication and number of genes), we look for the Pareto 
points [14]. These points correspond to documents that are not 
dominated by others considering both criteria (i.e. they are the 
best ones considering one criterion alone and the best com-
promises based on both criteria). We then select k documents 
in these points. Finally, for the top-k documents, we obtain a 
rank that can be used by the expert to analyze a sequence3.
Experiments
Case study
In the framework of the PEPS-ST2I Gene Mining project, we 
mined real data produced by analysis of DNA microarrays 
(Affymetrix DNA U133 plus 2.0) [10]. The aim was to deci-
pher brain aging mechanisms. Aging is the primary risk factor 
in neurodegenerative disorders such as Alzheimer's disease. 
We analyzed the transcriptome from the temporal cortex of 
Microcebus murinus, a relevant primate model because as 
they age, some of them present the same lesions observed in 
human brains affected by Alzheimer's disease. Primates were 
divided into 3 groups: 6 young adults, 10 healthy aged and 2 
aged with Alzheimer's disease lesions. We used DBSAP [10] 
to discover sequential patterns with several parameters. In the 
worst case, we obtained approximately 50,000 gene sequen-
ces. The longest sequence was composed of eight genes. 
These sequences can be used to distinguish between AD ani-
mals and healthy animals. However, as this number of se-
quences is too huge, the process of interpretation described in 
[9] cannot be directly applied on these sets of sequences.
3 Information on the visualization tool is available at: 
http://www.lirmm.fr/~bringay/Bringay/MedInfo/MedInfo.html
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Evaluation of popular and innovative sets
To identify relevant sequences, we analyzed popular and in-
novative genes and gene sequences. The topic we sued was 
“Alzheimer” and we varied the four other parameters: 
???????????? (10, 50, 100), ??????????? (0.25, 0.5, 0.75), 
???????????? (5, 10, 30), and ??????????? (0.25, 0.5, 0.75).
We obtained quantitative results that varied with the values of 
the parameters4. For example, from a set of 50,000 sequences, 
with the parameters ?????????????????? ?????????????????
???????????????? and ???????????????, we obtained ???
popular and ??? innovative sequences. The important issue is 
that we defined two sets of sequences in a quantity which al-
lows the use of the process described in [9]. The choice of the 
parameters depends on the number of sequences we define at 
the beginning of the process.
Evaluation of the ranking documents
In the first part of these experiments, we showed that we were 
able to help experts to select relevant patterns. The next step 
was to evaluate the quality of the NoDisco documents associ-
ated with these patterns. To this end, we arbitrarily selected
five popular sequences (see figure 2) and studied them in col-
laboration with experts. We built three sets of ranked docu-
ments: (i) We ranked them according to their ??? score 
?〈?????? (ii) We chose the first Pareto points, (iii) We ex-
tracted the first documents returned from PubMed using the 
names of the genes.
seq 1: ADAMTS9-APOE-KCNC1-PTPRA-LOC284214
seq 2: GSTO1-VAMP2-SMARCA2-PTPRA-UBE1DC1-CART
seq 3: ADAMTS9-PML-UBN1-FAT-SRRM2
seq 4: ADAMTS9-PML-PRLH-FAT-NBS1-RBX1-LOC284214
seq 5: ADAMTS9-PLXNA2-GSK3B-FAT-FLJ11029-DNAJB6
Figure 2: Five gene sequences
No. of doc. 10 20 30 40 50 60 70 80 90 100
%PubMed 
vs. Sdoc
0 2 4 4 4.8 4.3 4.2 4.2 3.7 3.4
%PubMed 
vs. Pareto
2 2 2.6 2 1.6 1.3 1.1 1 0.9 0.8
%Pareto vs. 
Sdoc
0 0 2 2 2.8 7 6.5 5.7 5.1 4.6
Table 1: Search for shared documents with the three methods
Methods PubMed ????? Pareto
Number of doc. 404 537 225
Table 2: Number of documents retrieved with the 3 methods
Evaluation PubMed ????? Pareto
1 13 6 9
2 0 4 0
3 2 6 0
4 1 1 2
5 4 3 9
Table 3: Evaluation of the documents by the expert
4 Due to lack of space, all results are not reported here, but are available at: 
http://www.lirmm.fr/~bringay/Bringay/MedInfo/MedInfoResults.pdf
Are the documents returned by the different methods the 
same? For each pair of methods, we computed the number of 
shared documents considering the 10, 20 … 100 first docu-
ments in each ranking list (see Table 1). Results corresponded
to the average number of documents obtained by the five se-
quences. For instance, we compared the 30 first documents 
sorted by PubMed and Sdoc.. In this case, we obtained an aver-
age of 4% of shared documents with both methods. Table 1 
shows that the three approaches returned different documents 
(i.e. we extracted new knowledge that was not discovered by 
querying PubMed alone). These experiments were based on a 
large number of documents (1,083 different documents re-
turned using our approaches).
Finally, the number of documents returned by the different 
approaches with the five sequences was very different. Table 2 
shows that method Sdoc returned a larger number of documents. 
This specific retrieval task (i.e., by generating a specific 
query) may be very useful for experts. This result can be ex-
plained by the fact that our method Sdoc takes into account 
synonyms to extract relevant documents. The number of 
documents returned by the Pareto method was low because 
this method rejects all documents that are not in the Pareto 
front (i.e. dominated documents [14]).
Are the documents returned by our methods relevant? To go 
deeper into the analysis of the documents, we asked an expert 
to analyze the abstracts of the first documents retrieved. He 
manually analyzed the 10 first abstracts retrieved by seq1 and 
seq2 using our three ranking methods (60 documents were 
manually analyzed). He classified them in five groups: (1) 
Relevant; (2) Too old (e.g. documents published before 2000 
were not relevant because they were published before the cre-
ation of the Affymetrix DNA microarray) (3) Semantically not 
relevant (e.g., documents with the term CART in their sum-
mary meaning Classification And Regression Tree instead of 
the gene CART) (4) Off the topic (e.g. documents retrieved in 
a journal of acupuncture are not relevant for biologists) (5) 
Not related to the sequence. When no term corresponding to 
one of the genes or to one of the aliases occurred in the ab-
stract, the expert was unable to evaluate the relevance of a 
document. The classification is summarized in Table 3.
Queries based only on PubMed returned the best rate of rel-
evant documents but the results of the two other methods (Sdoc 
and Pareto) can be easily improved: The noise corresponding 
to irrelevant documents can be easily reduced by adding do-
main knowledge to our method. 
First, we can consider documents published before 2000 to be 
less important. For example, we retrieved several documents 
dealing with PTP, (Pancreatic Thread Protein), published be-
fore 1999. These documents were not relevant for the biolo-
gists concerned, who were looking for information about 
PTPR4, Tyrosine Phosphatase Receptor, which is tested with 
Affymetrix microarrays. These two different proteins are 
linked by the same alias, but we can distinguish between them 
by the publication date.
Second, we can extend the topic to similar topics. For exam-
ple, we did not retrieve any documents with the association 
VAMP2 and AD but had better result with “aging”. When a 
query does not produce the expected result, the topic can be 
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extended by consulting a list of related topics. The concept of 
family can be used in the same way. The genes are organized 
according to their properties or functionalities. For example, 
KCNC1 did not produce result with AD, but KCNC (subunit 
of the potassium channel family) did produce results. Thus, 
when there is no result, the query can be extended by using the 
family as the term of the query instead of its alias.
Discussion 
Some tools are now able to mine the biological literature. 
BioMinT [15] is an easy-to-use information retrieval and ex-
traction tool targeted at online biomedical literature. This tool 
retrieves relevant documents and proposes a range of relevant 
outputs. However, the tool is not dedicated to the analysis of 
genes. From a set of genes defined by the user, MedMiner 
[11] filters and organizes large amounts of textual and struc-
tured information retrieved by public search engines (Gene-
Cards and PubMed). GoMiner [12] goes a step further and 
uses the Gene Ontology (GO) to identify biological processes, 
functions and components in a list of genes, and generates
hypotheses to guide further searches.
Although existing tools are very powerful, they are not dedi-
cated to the analysis of gene sequences produced by analysis 
of DNA microarrays. With NoDisco, popular sequences can 
be identified that will be useful to biologists to validate the 
gene sequences they identify. Indeed, these sequences are 
composed of genes that have already been linked in the litera-
ture and are well known. It is also possible to identify innova-
tive sequences, revealing surprising associations of genes, 
which can draw the attention of the biologist to unknown gene
interactions. For example, the expert who collaborated with us
identified an innovative gene ADAMTS9. This gene is not yet 
known to be involved in Alzheimer disease (i.e. there is no 
publication dealing with ADAMTS9 and “Alzheimer”). How-
ever, in the sequences, this gene is linked to popular genes that 
are well known for their implication in Alzheimer disease.
Moreover, the expert underlined the fact that two other genes 
in the same family, ADAM9, ADAM10 and ADAM17, have 
already been linked to Alzheimer disease, so the link between 
ADAMTS9 and Alzheimer needs to be studied.
Conclusion 
The development of DNA microarray technologies and the 
explosion of online scientific biological literature overwhelm 
the ability of researchers to take full advantage of available 
knowledge. In this paper, we presented the NoDisco process 
which enables biologists to select relevant sequences obtained 
from DNA microarray analysis. According to a topic, biolo-
gists can identify popular and innovative genes along with the 
sequences in which these genes appear. We also linked gene
sequences to the top-k documents in order to facilitate their 
interpretation. As discussed in the Experiments section, the 
relevance of the ranking in NoDisco can be easily extended to 
include domain knowledge. Moreover, NoDisco can be ex-
tended to other areas involving medical or pharmacological 
information. More generally, NoDisco can be used to organize 
the information retrieved from any arbitrary PubMed search.
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